International B2B and business intelligence group Informa has announced the sale of its Pharma Intelligence operation to private equity firm Warburg Pincus for a fee totalling £1.9bn.
A leading provider of specialist intelligence and data for clinical trials, drug development and regulatory compliance, Pharma Intelligence accounted for 40% of the £305m revenues reported for the company’s Informa Intelligence division in 2020.
Informa will retain a 15% stake in the business going forward and has also announced plans for a new round of share buybacks.
Deal value: £1.9bn
Email firstname.lastname@example.org to point out mistakes, provide story tips or send in a letter for publication on our "Letters Page" blog